Last updated: July 1, 2025
Sponsor: University of Alabama at Birmingham
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Genitourinary Prolapse
Treatment
Platelet rich plasma (PRP) Injection
Placebo
Clinical Study ID
NCT05731284
IRB-300009943
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Desire surgical treatment via a transvaginal native tissue approach.
Completed child-bearing
Exclusion
Exclusion Criteria:
Unable to follow-up, not willing to, or unable to participate in the proposed study
Prior pelvic surgery within the past 12 months
Prior anterior/apical suspension procedures
Prior graft augmented prolapse surgery
Pelvic/abdominal radiation
Pelvic mass
History of solid organ malignancy
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Platelet rich plasma (PRP) Injection
Phase:
Study Start date:
July 01, 2023
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
University of Alabama at Birmingham
Birmingham, Alabama 35249
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.